ABUS $3.51 (+0.00%) Quote details
Add to Watchlist Run Backtest
Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Arbutus Biopharma Corp

NASDAQ | ABUS

3.51

USD

+0 (+0.00%)

AT CLOSE (AS OF Apr 3, 2025)

$672M

MARKET CAP

-

P/E Ratio

-0.38

EPS

$4.7

52 Week High

$2.6

52 Week Low

LIFE SCIENCES

Sector

ABUS Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

ABUS Technicals

Tags:

ABUS Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$5.4M
Total Revenue $18M
Cost Of Revenue $24M
Costof Goods And Services Sold $74M
Operating Income -$78M
Selling General And Administrative $22M
Research And Development $74M
Operating Expenses $96M
Investment Income Net $5.7M
Net Interest Income -$459K
Interest Income $5.2M
Interest Expense $459K
Non Interest Income $145K
Other Non Operating Income -
Depreciation $1.4M
Depreciation And Amortization $1.4M
Income Before Tax -$73M
Income Tax Expense $0
Interest And Debt Expense $459K
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -$71M
Ebit -$72M
Ebitda -$71M
Net Income -$73M

Revenue & Profitability

Earnings Performance

ABUS Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (CAD)
Total Assets $144M
Total Current Assets $132M
Cash And Cash Equivalents At Carrying Value $26M
Cash And Short Term Investments $132M
Inventory -$1.8M
Current Net Receivables $1.8M
Total Non Current Assets $12M
Property Plant Equipment $4.7M
Accumulated Depreciation Amortization Ppe $12M
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments $100M
Long Term Investments $6.3M
Short Term Investments $100M
Other Current Assets $4.2M
Other Non Current Assets $0
Total Liabilities $38M
Total Current Liabilities $22M
Current Accounts Payable $3.2M
Deferred Revenue $24M
Current Debt -
Short Term Debt $425K
Total Non Current Liabilities $8.9M
Capital Lease Obligations $1.8M
Long Term Debt $0
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $0
Other Current Liabilities $7M
Other Non Current Liabilities $15M
Total Shareholder Equity $106M
Treasury Stock -
Retained Earnings -$1.3B
Common Stock $1.3B
Common Stock Shares Outstanding $170M

yearly Cash Flow (As of Dec 31, 2023)

Field Value (CAD)
Operating Cashflow -$86M
Payments For Operating Activities $598K
Proceeds From Operating Activities -
Change In Operating Liabilities -$6.2M
Change In Operating Assets $1.4M
Depreciation Depletion And Amortization -$792K
Capital Expenditures $1M
Change In Receivables $424K
Change In Inventory $6.2M
Profit Loss -$73M
Cashflow From Investment $51M
Cashflow From Financing $31M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $795K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$73M

yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$5.4M
Total Revenue $18M
Cost Of Revenue $24M
Costof Goods And Services Sold $74M
Operating Income -$78M
Selling General And Administrative $22M
Research And Development $74M
Operating Expenses $96M
Investment Income Net $5.7M
Net Interest Income -$459K
Interest Income $5.2M
Interest Expense $459K
Non Interest Income $145K
Other Non Operating Income -
Depreciation $1.4M
Depreciation And Amortization $1.4M
Income Before Tax -$73M
Income Tax Expense $0
Interest And Debt Expense $459K
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -$71M
Ebit -$72M
Ebitda -$71M
Net Income -$73M

ABUS Profile

Arbutus Biopharma Corp Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania.

DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
BTG
-0.17%
$2.915
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
BTG
-0.17%
$2.915
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.